Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jul 21, 2014
Emerging Company Profile
Envisia: Ophthalmic nanotechnology
...Undisclosed Funds raised: $25 million Investors: Canaan Partners; New Enterprise Associates; Morningside Group; Pappas Ventures;
Wakefield Group
...
Read More
BioCentury
|
Nov 18, 2013
Financial News
Envisia Therapeutics completes venture financing
...financing Raised: $25 million Investors: Canaan Partners; New Enterprise Associates; Pappas Ventures; Morningside Technology Ventures;
Wakefield Group
WIR...
Read More
BioCentury
|
Nov 13, 2013
Financial News
Liquidia spins out ophthalmic newco Envisia
...series A round from Canaan Partners; New Enterprise Associates; Pappas Ventures; Morningside Technology Ventures; and
Wakefield Group
...
Read More
BioCentury
|
Aug 25, 2003
Finance
Ebb & Flow
...Development Corp.; Mitsui & Co.; Dow Chemical Co. ; Dogwood Equity; Trelys Street Partners; The
Wakefield Group
...
Read More
BioCentury
|
Aug 20, 2003
Financial News
Biolex raises $24.4 million
...Corp.; Mitsui & Co.; The Dow Chemical Co. ; Dogwood Equity; Trelys Street Partners; The
Wakefield Group
...
Read More
BioCentury
|
Nov 5, 2001
Emerging Company Profile
Corporate Profile
...Street Partners; S.R. One; Elan Corp. plc; Cordova Technology Partners; Kitty Hawk Capital; Aurora Ventures;
Wakefield Group
...
Read More
BioCentury
|
Apr 4, 2000
Financial News
Cogent raises $15 million
...Durham, N.C.) raised $15 million in a private placement. Investors included Franklin Street Partners; The
Wakefield Group
...
Read More
Items per page:
10
1 - 7 of 7
BioCentury
|
Jul 21, 2014
Emerging Company Profile
Envisia: Ophthalmic nanotechnology
...Undisclosed Funds raised: $25 million Investors: Canaan Partners; New Enterprise Associates; Morningside Group; Pappas Ventures;
Wakefield Group
...
Read More
BioCentury
|
Nov 18, 2013
Financial News
Envisia Therapeutics completes venture financing
...financing Raised: $25 million Investors: Canaan Partners; New Enterprise Associates; Pappas Ventures; Morningside Technology Ventures;
Wakefield Group
WIR...
Read More
BioCentury
|
Nov 13, 2013
Financial News
Liquidia spins out ophthalmic newco Envisia
...series A round from Canaan Partners; New Enterprise Associates; Pappas Ventures; Morningside Technology Ventures; and
Wakefield Group
...
Read More
BioCentury
|
Aug 25, 2003
Finance
Ebb & Flow
...Development Corp.; Mitsui & Co.; Dow Chemical Co. ; Dogwood Equity; Trelys Street Partners; The
Wakefield Group
...
Read More
BioCentury
|
Aug 20, 2003
Financial News
Biolex raises $24.4 million
...Corp.; Mitsui & Co.; The Dow Chemical Co. ; Dogwood Equity; Trelys Street Partners; The
Wakefield Group
...
Read More
BioCentury
|
Nov 5, 2001
Emerging Company Profile
Corporate Profile
...Street Partners; S.R. One; Elan Corp. plc; Cordova Technology Partners; Kitty Hawk Capital; Aurora Ventures;
Wakefield Group
...
Read More
BioCentury
|
Apr 4, 2000
Financial News
Cogent raises $15 million
...Durham, N.C.) raised $15 million in a private placement. Investors included Franklin Street Partners; The
Wakefield Group
...
Read More
Items per page:
10
1 - 7 of 7
Previous page
Next page